ICON Launches New Analytics Service for Advanced Medical Review of Laboratory Data
News Nov 19, 2013
ICON plc has announced ICONIK Labs, the latest service to leverage its ICONIK technology platform.
ICONIK Labs is an interactive analytics tool that allows Clinical and Medical team members to visualize, analyze and report on large volumes of laboratory data in real time.
Using ICONIK Labs’ advanced visualization capabilities, project teams can interact with data and view trends at any level of detail, including patient, site, study or across an entire program through a series of dynamic filters.
ICONIK Labs enhances a study’s quality by instantly identifying sites with an unusual number of lab values outside the normal range and can also improve patient safety by providing Hy’s Law analysis which assists with the detection of subjects at risk of Drug Induced Liver Injury (DILI).
Commenting on the new service, Dr. Steve Cutler, Group President, ICON Clinical Research Services, said: “ICONIK Labs has transformed how study teams review and analyze laboratory data and has enabled a fresh approach to combining lab parameters to review study trends. It enables study teams to quickly uncover actionable insights that support earlier, more informed decision-making and more efficient trial management.”
ICONIK Labs is the latest service to leverage the ICONIK technology platform and follows ICON’s recent announcement of ICONIK Monitoring and ICONIK Patient Safety.
ICONIK Monitoring is a new service that improves quality and reduces the costs of clinical development through more effective use of monitoring resources.
ICONIK Patient Safety enables real-time analysis of aggregated patient safety data, giving study teams the ability to uncover potential medical issues in real-time.
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE